Duchenne Muscular Dystrophy, Respiratory Function Test, Upper Limb Function
Conditions
Brief summary
Although it is known that the functions of pulmonary and upper limb is affected in late stage of Duchenne Muscular Dystrophy (DMD) negatively, the investigators do not have clear information about its early stage. The aim of this study was to investigate the differences in pulmonary and upper limb functions between children with DMD in early stage and healthy peers.
Interventions
OTHERThe Performance of Upper Limb Questionnaire (PUL)
Sponsors
Hacettepe University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
5 Years to 10 Years
Healthy volunteers
Yes
Inclusion criteria
children with DMD was; * age between 5-10 years * being on treatment with corticosteroids for more than 6 months * being at Level I according to Brooke Upper and Lower Extremity Classification Systems Healthy peers; * age between 5-10 years * not having any diagnosed disease
Exclusion criteria
• Children has undergo surgery and disease affect upper extremity or pulmonary function in last six months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pulmonary Function Test (PFT) | 5 minutes | The pulmonary function tests of the participants were evaluated with a spirometry. The child was asked to perform the spirometric tests for three times with maximum effort. The child was motivated before each attempt for stronger and longer expiration.The result of Pulmonary function Test were recorded. |
| The Performance Upper Limb (PUL) | 15 minutes | Upper limb functions of participants were evaluated with The Performance of Upper Limb (PUL) scale. This scale, which was shown to be reliable in DMD, has 22 items in total. It consists of 3 different levels of function: high, mid, and distal. PUL also has four items determining timed performance. |
Outcome results
None listed